MARK FOLETTA

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

DEXCOM INC

Filing Date Source Excerpt
2018-04-20 Mr. Foletta received a B.A. in Business Economics from the University of California, Santa Barbara and is a member of the Corporate Directors Forum.
2019-04-19 Mr. Foletta has been the Chief Financial Officer and Executive Vice President of Tocagen, Inc. and held CFO roles at Amylin Pharmaceuticals.

Source material: SEC submissions metadata and DEF 14A proxy filings from EDGAR. Last updated: 2026-03-22